Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Click to enter a date Choose an item Enter First & Last Name [ INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The Nevada Oncology Society (NOS) Board of Directors invites [ INSERT YOUR COMPANY’S NAME HERE] to attend and display at our NOS 2022 Fall Conference on November 10, 2022 at the Whitney Peak Hotel in Nevada. The $2,500 registration fee …
Click to enter a date Choose an item Enter First & Last Name [ INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The Arizona Clinical Oncology Society (TACOS) Board of Directors invites [ INSERT YOUR COMPANY’S NAME HERE] to attend and display at our TACOS 2022 Fall Conference on November 12, 2022 at the Pointe Hilton Tapatio Cliffs in Arizona. The …
Click to enter a date Choose an item Enter First & Last Name [ INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The Hawaii Society of Clinical Oncology (HSCO) Board of Directors invites [ INSERT YOUR COMPANY’S NAME HERE] to attend and display at our HSCO 2022 Annual Conference on November 5, 2022 at the Kahala Hotel in Hawaii. The $3,000 registration …
Tom Vibert was diagnosed with Stage 4 metastatic colon cancer in 2014. Learn how participating in a clinical trial allowed Vibert to get back on the bike and beat his cancer.
With the emergence of oral cancer therapies, it is a very exciting time in cancer care. But these treatments can come with adverse events.
In a letter to Senate Leaders Schumer and McConnell on the current version of a reconciliation package including prescription drug reform provisions, ACCC expressed concerns about the impact of Medicare drug price negotiation on Part B drug reimbursement. As proposed, these reimbursement cuts would significantly reduce beneficiary access to crucial medications and treatments and also threaten the financial …
Dr. Barbara Schmidtman discusses how life's challenges have taught her to embrace joy in the workplace through redefining "failure" and taking control of the uncontrollable.
Fox Chase Cancer Center CAR T-cell Practice Profile This article explores the approach that Fox Chase Cancer Center took to deliver CAR T-cell therapies for patients from community cancer programs and its lessons learned. Fox Chase Cancer Center at Temple University Hospital, Philadelphia, PA, is a national leader in cancer research and treatment. Henry Chi Hang Fung, MD, FACP, …
Billings Clinic Cancer Center CAR T-cell Practice Profile This article explores the approach of Billings Clinic Cancer Center to establishing the infrastructure to deliver CAR T-cell therapy in the community and its lessons learned. Billings Clinic provides quality oncology specialty services to individuals in a vast geographic area and is one of the largest health systems in …
From clinical trial site to one of the few institutions in the country authorized to deliver all available FDA-approved CAR T-cell therapies, Fox Chase Cancer Center describes its successful evolution and identifies effective practices to help community cancer centers surmount the financial barriers to therapy as well as build strong referral networks with institutions offering cellular therapies.
As one of the largest health systems in Montana, the Billings Clinic Cancer Center describes its approach to establishing the infrastructure necessary to deliver CAR T-cell therapy in the community and how its strategies can be implemented by other community cancer centers across the country.
Dr. David Eagle shares why grassroot advocacy efforts are so important to furthering health equity and person-centered care in oncology, including how state-based efforts curbed harmful pharmacy benefit manager practices in New York.
While patients with cancer face many physical and psychological challenges associated with their disease and/or treatment, their social, emotional, and legal needs can lead to ongoing health disparities and reduced quality of life if left unaddressed.
Alexandria, Va. And Rockville, Md. – The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) today jointly released two resources to help research sites increase the racial and ethnic equity, diversity, and inclusion (EDI) in cancer clinical trials. The Just ASK™ Increasing Diversity in Cancer Clinical Research: An ACCC-ASCO Training Program (Just …
Cancer Health Disparities and solutions through NOLA Kashyap Patel, MD, ABOIM, BCMAS President, Community Oncology Alliance Past Chairman, Clinical Affairs, Association of Community Cancer Centers Medical Director; Diversity, equity and inclusivity; International Oncology Network Past President, SCOS Private and confidential Learning objectives: • Current …
Integrative Cancer Care Donald I. Abrams, MD Professor Emeritus of Medicine University of California San Francisco Integrative Cancer Care “It is more important to know what sort of patient has a disease than what disease a patient has.” Moses Maimonides and Sir William Osler The patient we see and the person we may not Although we treat the patient in front …
July 25, 2022
An online implicit bias training program that presents the broader context of structural and systemic racism, the role of implicit bias in clinical trial selection, vignettes with real-world examples of implicit bias, and guidance for mitigating disparities in cancer research settings.
The complex needs of patients with cancer require a more proactive approach to their care. Ochsner Health, Ochsner Cancer Institute in Louisiana implemented a program—Chemotherapy Care Companion—to identify and meet patients’ needs in real time.
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials (DDiCT) Initiative to Improve Healthcare Outcomes for People with Disabilities (PRINCETON, N.J., July 20, 2022) - Bristol Myers Squibb NYSE (BMY) today announced, in collaboration with Disability Solutions, a U.S.- based non-profit organization that supports companies globally to achieve true disability …